9 hours ago

Tom Winnifrith Video Shareshow No 15: Stuart Ashman runs what could be a 20 bagger and Lucian Miers on his longs and shorts

And now from Wales, by just 30 yards, it is my new weekly video show. This costs 99p per episode, and you can either listen to, or watch, some sparky interviews with Staurt Ashman of Skinbiotherapeutics (SBTX) where I am 130% up in seven months but think the shares could 20 bag from here and bear raider Lucian Miers on macro economics his cooling feelings on cold and warming feelings on bitcoin and his big longs and shorts. Then there are a few thoughts on companies you must NOT own, including the latest nonsense from the scallywags at Powerhouse Energy (PHE).You can access the show HERE


4 days ago

Tom Winnifrith Bearcast: Another day of shame for AIM and why Sosandar is just not for me anymore

Today I look at three companies. I start with Skinbiotherapeutics (SBTX) where I ask if it is better to travel than to arrive? Then it is onto Sarah Willingham, Allenby Capital, The Sunday Times and their collective shame in the disgraceful AIM IPO of car crash in waiting Nightcap (NGHT). Finally I look at Sosandar (SOS).


9 days ago

Tom Winnifrith Bearcast: Steve O'Hara of Optibiotix blames interviews with me for share price weakness

Yup, if he does an interview with me and my tough questions, shares in Optibiotix (OPTI) go down.  So, going forward, it is only those paid-for interviews with folks like Proactive. “Steve, is your schlonger enormous or gigantic? Why are your shares so cheap? etc etc.” Whatever, I apologise to you all for asking the odd question. Without my malign influence, Optibiotix would clearly be in the FTSE 100. I discuss this company’s prospects and also those of Skinbiotherapeutics (SBTX) where I am also a loyal shareholder. I look at Trainline (TRN), Online Blockchain (OBC) and Vast Resources (VAST).


64 days ago

Tom Winnifrith Bearcast: Chatting to Steve O'Hara

In today’s podcast I look at Cineworld (CINE), Trainline (TRN), Novacyt (NCYT), Powerhouse Energy (PHE), Optibiotix (OPTI) and Skinbiotherapeutics (SBTX).


91 days ago

Skinbiotherapeutics placing at 16p – why am I not impressed? But through gritted teeth a buyer

Skinbiotherapeutics (SBTX) boss Stuart Ashman until today held zero shares in the company. And he told us all that it had enough cash to last it until the end of next year at least.  And so now there is a £4 million placing and £500,000 open offer at 16p.  Mr Ashman can you see why I might be annoyed?


93 days ago

Tom Winnifrith Bearcast: back in Wales no thanks to an AA confused by Sheep

I am back here at last and allow a bit of time for personal matters. Then it is on to Optibiotix (OPTI), Skinbiotherapeutics (SBTX), Verditek (VDTK) and G3 Exploration (G3E).


164 days ago

SkinBiotherapeutics: more good news, increased targets upgrade of stance

On 26 May 2020, Steve and I tipped SkinBiotherapeutics (SBTX) at a 17.75p offer and at up to 20p with a target price of 30p. News last week suggests that, notwithstanding this company wasting a few grand a month employing the biggest knobhead in Christendom to do its PR, we were more than a tad conservative and the shares now trade at 22p-23.5p and are still dirt cheap.


185 days ago

Tom Winnifrith Shareshow No 6: 2 hours 17 mins of Richard Poulden on the collapse of the west and of empires, Kerim Sener of Ariana and me on [email protected] capital and 6 more shorts

And now from Wales, by just 30 yards, it is my new, I hope, weekly video show. This costs 99p per episode, and you can either listen to, or watch some sparky interviews with Richard Poulden on the collapse of empires but also of the West at every level.  Also covered is the death of oil and how we should save our finances against such a backdrop and with Kerim Sener of Ariana (AAU). I also explain why [email protected] Capital (SYME) is a crooked zero and I review the six short ideas from the previous five shows, one of which is already a zero. 

You can access the show HERE


185 days ago

SkinBioTherapeutics – “Business Update”, remains a buy...

SkinBioTherapeutics (SBTX) has updated that it is “very pleased with the progress that the company has been able to make during these most exceptional times”, particularly including “several months ahead of schedule, Winclove has now been able to successfully combine and formulate the blend as a probiotic food supplement, to be known as AxisBiotix ™Ps”


188 days ago

Skinbiotherapeutics, the most idiotic of PR men and an email exchange

There are only two financial journalists who write regularly about Skinbiotherapeutics (SBTX): myself and Steve Moore. Coverage elsewhere is minimal to zero yet for some reason the company wastes the cash of loyal shareholders such as myself, on Instinctif, a financial PR firm.  Yesterday at 4.16PM on trading statement day Mr Phillip Marriage of Instinctif dropped me an email. I suspect he wishes he had not.  Our full exchange follows.